End-of-day quote Korea S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
110,100 KRW +0.46% Intraday chart for HLB Co., Ltd. +10.10% +117.16%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd. CI
HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8% MT
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 29.99999658 billion in funding from HLB Co., Ltd. and other investors CI
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
HLB Co., Ltd. announced that it has received KRW 60 billion in funding from a group of investors CI
HLB Co., Ltd. announced that it expects to receive KRW 60 billion in funding from a group of investors CI
Bank of Canada Holds Rates Steady; ECB Expected -2- DJ
South Korean Shares Marginally Decline for Second Day on Profit-Booking MT
HLB Shareholders Endorse Transition to Main Bourse from KOSDAQ MT
BPH Energy Appoints HLB Mann Judd as Auditor; Shares Plunge 10% MT
Century Sunshine Group’s Auditor Resigns; Successor Named MT
Rare Earth Magnesium’s Auditor Steps Down; Successor Appointed MT
Jinhai International Gets New Auditor MT
HLB Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
HLB, Hong Leong Islamic Bank, Cagamas Conclude MYR300 Million Green Assests Deal MT
Spenda Halts Trade Pending Court Nod for Auditor Appointment MT
5E Resources Appoints New Auditors MT
Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd. CI
Elevar Therapeutics, Inc. announced that it expects to receive KRW 58.174676146 billion in funding from HLB Co., Ltd. CI
Hong Leong Bank Digital Banking Platforms Grow 22% as of May MT
Panagene Inc. announced that it expects to receive KRW 56.599994061 billion in funding from a group of investors CI
Panagene Inc. announced that it expects to receive KRW 46.068324061 billion in funding from HLB Co., Ltd., HLB Investment Co., Ltd., HLB bioStep Co.,Ltd., HLB innoVation Co.,Ltd., HLB Therapeutics Co.,Ltd. CI
HLB Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ban Loong Appoints New Auditor MT
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Chart HLB Co., Ltd.
More charts
HLB Inc is a Korea-based company mainly engaged in the manufacture and sale of lifeboats and pipes. The Company operates its business through two segments. The Composite Material segment is mainly engaged in the construction and repair of lifeboats, the manufacture and installation of pipes. The Biomedical Device Business segment is mainly engaged in the development of biopharmaceuticals, the manufacture and sale of medical devices.
More about the company
  1. Stock Market
  2. Equities
  3. A028300 Stock
  4. News HLB Co., Ltd.
  5. HLB, Hong Leong Islamic Bank, Cagamas Conclude MYR300 Million Green Assests Deal